Skip to main content
    C

    Cellectis SA (CLLS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.06
    +0.02 (+1.92%)

    Market Cap: $118.86M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Cellectis SA (CLLS) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Cellectis SA (CLLS) has a latest price of $1.06 on Nov 17, 2026, 80.6% below its 52-week high of $5.45. Its price fell 72.8% over the past 12 months. The month-end price fell 93.9% over the 10 years through Oct 2026, a compound annual decline of 24.4%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $35.01 in Oct 2017 and its lowest $0.97 in Oct 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CLLS with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CLLS.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 66.6%, and over 6 months it fell 70.8%. The month-end price rose 11.3% over the 3 years through Oct 2026, a compound annual rate of 3.6%.

    PeriodChange
    1 month+14.5%
    3 months-66.6%
    6 months-70.8%
    12 months-72.8%
    12 months, with dividends-72.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+11.3%+3.6%
    5 years-90.0%-36.9%
    10 years-93.9%-24.4%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 168.9%, and its weakest was 2022, when it fell 74.1%.

    YearCloseChange
    2026 through Oct 2026$1.08-77.7%
    2025$4.84+168.9%
    2024$1.80-41.6%
    2023$3.08+46.7%
    2022$2.10-74.1%
    2021$8.12-70.0%
    2020$27.06+58.1%
    2019$17.12+2.8%
    2018$16.65-42.9%
    2017$29.15+72.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 22.1% below its 50-day average of $1.36 and 63.3% below its 200-day average of $2.89.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.06
    52-week high$5.45-80.6%
    52-week low$0.88+20.3%
    50-day average$1.36-22.1%
    200-day average$2.89-63.3%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 82.7%.

    MeasureValue
    1-year beta2.36
    Largest fall, 1 year-82.7%
    Largest fall, 3 years-82.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CLLS

    What is CLLS's 1-year price change?

    Cellectis SA's price fell 72.8% over the past 12 months. With dividends included, the 12-month total return was -72.8%.

    What is CLLS's 5-year price change?

    Cellectis SA's month-end price fell 90.0% over the 5 years through Oct 2026, a compound annual decline of 36.9%. These figures leave out dividends.

    What is CLLS's 52-week high and low?

    Cellectis SA's 52-week high is $5.45 and its 52-week low is $0.88. Its latest price of $1.06 on Nov 17, 2026 is 80.6% below the high.

    What is CLLS's beta?

    Cellectis SA's 1-year beta against the S&P 500 is 2.36, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 82.7%.

    Is the CLLS chart free?

    Yes. Advanced Charting for CLLS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.